Bicillin L-A vs Placebo for the Treatment of Chronic, Plaque-Type Psoriasis Unresponsive to Topical Medications
Status:
Terminated
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy for Bicillin L-A, administered
intramuscularly in a dose of 2.4 million units every three (3) weeks, for the treatment of
chronic, plaque-type psoriasis unresponsive to topical medications or when other systemic
therapies are contraindicated.
Phase:
Phase 2
Details
Lead Sponsor:
University of Tennessee
Treatments:
Penicillin G Penicillin G Benzathine Penicillin G Procaine